2006
DOI: 10.1080/02841860600902213
|View full text |Cite
|
Sign up to set email alerts
|

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
73
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 114 publications
(73 citation statements)
references
References 19 publications
0
73
0
Order By: Relevance
“…Usually, the PTV margin is larger in the cranio-caudal direction in SBRT, considering that the tumor motion is larger in the cranio-caudal direction than in the lateral and antero-posterior directions (8,21,22). However, no increase in the PTV margin for the cranio-caudal direction was used in this study considering that RTRT can reduce the size of the margin for respiratory movement.…”
Section: Radiotherapymentioning
confidence: 91%
“…Usually, the PTV margin is larger in the cranio-caudal direction in SBRT, considering that the tumor motion is larger in the cranio-caudal direction than in the lateral and antero-posterior directions (8,21,22). However, no increase in the PTV margin for the cranio-caudal direction was used in this study considering that RTRT can reduce the size of the margin for respiratory movement.…”
Section: Radiotherapymentioning
confidence: 91%
“…Patients were treated with SBRT in Novalis (BrainLAB, Feldkirchen, Germany) platform for a total dose of 60 Gy in three fractions ( 14 ) or 30 Gy in a single fraction (www.ClinicalTrials.gov identifier: NCT00843726, a phase III trial led by Roswell Park Cancer Institute, Buffalo, NY). Treatment plans were designed using dynamic conformal arcs with 6 MV photon beams in iPlan RT 4.1.2 TPS following the protocol guidelines.…”
Section: Methodsmentioning
confidence: 99%
“…( 7 ) Currently, dose calculation algorithms with heterogeneity correction are not consistent among different treatment planning systems, ( 8 12 ) depending on how the changes in lateral electron transport are taken into account. ( 13 ) For this reason, dose calculations without heterogeneity correction were required in RTOG 0236, ( 14 ) which was a phase II trial of SBRT in the early stages of medically inoperable NSCLC. This requirement is supported by the consistent performance of dose calculation algorithms in different treatment planning systems for homogeneous water.…”
Section: Introductionmentioning
confidence: 99%
“…The first such work began in 2002 when the Radiation Therapy Oncology Group in North America began the process of developing multicenter prospective trials in lung cancer using SBRT [31]. These activities have had an impact not only on the treatment received by patients enrolled in clinical trials, but also on the quality of treatment administered to all patients treated in each institution.…”
Section: Discussionmentioning
confidence: 99%
“…Many of these guidelines have been set forth by national and international professional organizations. However, the majority of such work in QA for radiosurgery has focused on the successful implementation of QA in the context of multi-centered clinical trials [25,[28][29][30][31]. Others have published practice guidelines endorsed by governing organizations for the performance of SBRT to serve as an educational tool designed to assist practitioners in providing appropriate care for patients [32].…”
Section: Introductionmentioning
confidence: 99%